Core Insights - Pfizer Inc has secured a three-year grace period from tariffs on pharmaceuticals promised by President Donald Trump, which is expected to lower some of the company's drug prices in the US [1] - The company will offer certain drugs at an average discount of 50% through a direct-to-consumer website named TrumpRx, aimed at providing Americans with access to discounted prescription prices negotiated by the government [1]